The Board of Partners of E. Merck KG, Darmstadt, Germany, appointed Kai Beckmann as future Chair of the Executive Board and CEO. Darmstadt, Germany Belén Garijo’s successful tenure to be completed as planned by end of April 2026 Kai Beckmann appointed as Chair of the Executive Board and CEO effective May 1, 2026, ensuring a […]
Mastermind® FLEX Data powers Compass Bioinformatics’s InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond while advancing precision medicine globally Ann Arbor, MI, USA and Tokyo, Japan – Genomenon, a leading genomic intelligence company, today announced a strategic partnership with Compass Bioinformatics, integrating Genomenon’s Mastermind FLEX Data into Compass Bioinformatic’s innovative […]
SALT LAKE CITY and BOSTON — Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the […]
Merck KGaA and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry. Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens Xcelerator Platform and Life Science portfolio of Merck KGaA, Darmstadt, Germany Joint projects include developing AI-driven […]
-Elevating Performance and Efficiency for Clinical and Public Health Labs- [Wilmington, DE] — LabWare, Inc., the global leader in Laboratory Information Management Systems (LIMS) for more than 30 years, today announces the release of Clinical Health Solution 5.06, the latest version of its purpose-built solution for managing clinical diagnostics and public health laboratory operations. This new release […]
MoU signed to deliver end-to-end digital workflows from drug discovery to manufacturing through combination of technology from the Siemens Xcelerator platform and Merck’s Life Sciences portfolio Joint projects include developing AI-driven tools and digital interfaces that simplify complex scientific processes Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership […]
BOSTON — SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS’s AI […]
Elevating Performance and Efficiency for Clinical and Public Health Labs WILMINGTON, Del. — LabWare, Inc., the global leader in Laboratory Information Management Systems (LIMS) for more than 30 years, today announces the release of Clinical Health Solution 5.06, the latest version of its purpose-built solution for managing clinical diagnostics and public health laboratory operations. This new release […]
The new co-marketing and distribution partnership enables SureSeq™ NGS panel customers to purchase QIAGEN’s tertiary analysis software QIAGEN Clinical Insight (QCI®) Interpret as part of a complete SureSeq NGS workflow solution, unlocking comprehensive analysis from sample to report QIAGEN Digital Insights bioinformatics bring over 25 years of expertise in expert-curated content, AI-powered proprietary algorithms and […]
Synthesize Bio’s generative genomics models predict the results of gene expression experiments with unprecedented accuracy Funding led by Madrona with participation from AI2 Incubator, Sahsen Ventures, Inner Loop Capital and Point Field Partners Synthesize Bio is actively engaging with biopharma partners to enable more confident drug development decisions using generative genomics GEM-1 foundation model now […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
